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Abstract. In drug discovery, it is important to
identify phase I metabolic modifications as early
as possible to screen for inactivation of drugs
and/or activation of prodrugs. As the major class
of reactions in phase I metabolism is oxidation
reactions, oxidation of drugs with TiO2
photocatalysis can be used as a simple non-
biological method to initially eliminate (pro)drug
candidates with an undesired phase I oxidation
metabolism. Analysis of reaction products is com-
monly achieved with mass spectrometry coupled to chromatography. However, sample throughput can be
substantially increased by eliminating pretreatment steps and exploiting the potential of ambient ionization mass
spectrometry (MS). Furthermore, online monitoring of reactions in a time-resolved way would identify sequential
modification steps. Here, we introduce a novel (time-resolved) TiO2-photocatalysis laser ablation electrospray
ionization (LAESI) MSmethod for the analysis of drug candidates. Thismethodwas proven to be compatible with
both TiO2-coated glass slides aswell as solutions containing suspended TiO2 nanoparticles, and the results were
in excellent agreement with studies on biological oxidation of verapamil, buspirone, testosterone, andarine, and
ostarine. Finally, a time-resolved LAESI MS setup was developed and initial results for verapamil showed
excellent analytical stability for online photocatalyzed oxidation reactions within the set-up up to at least 1 h.
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Introduction
Metabolism of drugs is an important aspect of their effica-cy after administration to the body. One aspect of human
metabolism is the excretion of xenobiotics—e.g., drugs or
carcinogens—by biochemical transformations. In pharmacolo-
gy, these transformations can also be exploited for the activa-
tion of prodrugs. The metabolism of drugs is often divided into
two phases, biotransformation and bioconjugation,
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respectively. The biotransformation, phase I, plays an impor-
tant role in the deactivation of drugs and activation of prodrugs
and comprises reactions such as oxidation, reduction, and
hydrolysis. In drug discovery, it is important to identify these
modifications as early as possible to screen for possible phar-
macologically active compounds [1, 2]. Commonly, the me-
tabolism of drug candidates is evaluated by in vitro biotrans-
formations (with microsomes or recombinant enzymes), which
are time-consuming and relatively expensive [2]. Since the
major class of reactions in phase I metabolism are oxidation
reactions [3], also non-enzymatic methods could be used for
rapid phase I reactions to eliminate drug candidates with an
undesired metabolism. Apart from electrochemistry ap-
proaches [4, 5], titanium dioxide (TiO2) photocatalysis is a
simple non-enzymatic method to generate oxidation reaction
products similar to those obtained by phase I biochemical
transformations [6–13].
In TiO2 photocatalysis (see refs [14, 15] for reviews), TiO2
is used as a material that is able to catalyze oxidation and
reduction reactions when exposed to ultra-violet (UV) radiation
[16–18]. The absorbance of a photon by TiO2 with an energy
greater than its bandgap (3.2 eV, 385 nm) will excite a valence
electron, producing a free electron in the conduction band and
leaving a hole in the valence band. Both the hole and free
electron can react with other molecules that are present at the
material surface, like molecular oxygen and water molecules.
Molecular oxygen can be reduced to superoxide (O2
−), which
is a very strong oxidizing agent of organic molecules [19]. In
both the oxidation (by photogenerated holes) and reduction (by
the free electrons) of water molecules, hydroxyl radicals are
produced. Hydroxyl radicals are highly oxidative and have
been used extensively as a tool for oxidation reactions with
drug candidates [6–13].
Mass spectrometry (MS), often coupled with liquid
chromatography (LC), is a well-established analysis tech-
nique for the identification and quantification of drugs and
their metabolites following in vitro and in vivo studies.
Hence, LC-MS has been used as analytical method of
choice for identification of the drug reaction products in
most TiO2 photocatalyzed oxidation studies [6–12]. This
method requires the removal of TiO2 particles prior to LC-
MS analysis, introducing pretreatment steps and thus lim-
iting sample throughput. Improvements have been
achieved with a nanoreactor electrospray ionization chip
(TiO2-μPESI) containing integrated TiO2-coated
micropillars for direct MS analysis [13]. Apart from this
approach, a simple TiO2-coated rotating platform was re-
cently introduced in combination with desorption
electrospray ionization (DESI) MS, providing the opportu-
nity to increase throughput of oxidation reactions up to
four samples per minute [20]. Although these MS methods
do not allow for the separation of isomeric reaction prod-
ucts, MS/MS provides information on the modification
site. A drawback in current TiO2 photocatalysis systems
is the possibility of continuous oxidation of formed reac-
tion products, as often multiple, consecutive oxidation
reactions might take place. This makes it difficult to iden-
tify sequential oxidation steps. An online, time-resolved
based method would therefore be a real asset for identifi-
cation of products, and to follow consecutive and/or paral-
lel modifications in real time.
Laser ablation electrospray ionization (LAESI) is an
ambient MS technique used in the analysis of, e.g., tissues,
food contaminants, solid materials, and liquids [21–29]. It
uses a 2.94 μm mid-infrared pulsed laser that addresses
hydroxyl moieties leading to the efficient ablation of sam-
ple material that is subsequently extracted by charged
electrospray droplets upon MS analysis. LAESI has previ-
ously been demonstrated its ability to allow monitoring of
enzymatic reactions in time, directly from a well plate [28].
In a LAESI TiO2 photocatalysis MS system, reaction prod-
ucts in the ablation plume would simply be extracted by
electrospray droplets for MS detection, without any need
for removal of TiO2 particles. Temporal resolution would
then easily be obtained by online UV exposure inside the
LAESI ambient ionization source, providing the opportu-
nity to study reactions in real time.
In the present work, we introduce LAESI-MS as an analysis
technique in TiO2 photocatalysis. The feasibility of the method
is demonstrated and critically compared to LC-MS, TiO2-
μPESI-MS, and DESI-MS TiO2 photocatalysis methods for
verapamil, buspirone, and testosterone. Furthermore, the meth-
od is used to generate reaction products of the selective andro-
gen receptor modulators andarine and ostarine and compared
with metabolites obtained in vitro. Finally, time-resolved TiO2
photocatalysis LAESI-MS is shown, with the online TiO2




TiO2-coated glass slides were created by atomic layer de-
position of titanium(IV) isopropoxide on glass; the full
procedure has been reported elsewhere [20]. Verapamil,
buspirone, and titanium(IV) oxide nanopowder P25 were
o b t a i n e d f r om S i gm a -A l d r i c h ( Zw i j n d r e c h t ,
The Netherlands). Testosterone, ostarine, and andarine were
kindly donated by RIKILT (Wageningen, The Netherlands).
Ultrapure water (H2O)—18.2 MΩ × cm
−1 at 25 °C—was
freshly produced daily with a Millipore (Molsheim, France)
Integral 3 system. Acetonitrile (ACN) LC-MS grade was
bought from VWR (Leuven, Belgium). Methanol (MeOH)
UPLC-MS grade was purchased f rom Bioso lve
(Valkenswaard, The Netherlands). Formic acid (FA) LC-
MS grade was bought from Fisher Scientific (Geel, Bel-
gium) and leucine-enkephalin (leu-enk) for lock mass-
corrected mass calibration was purchased from Waters
(Manchester, UK).
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LAESI-MS of TiO2 Photocatalyzed Oxidation Re-
actions on Glass Slides
For all compounds, only 1 μL of sample solution (1 mM) was
dispensed on TiO2-coated glass slides. The sample spots were
UV exposed until dry—roughly between 60 and 180 s, depend-
ing on solvent volatility—with a Uvet (Guangdong, P.R. China)
UV LED Spot Curing System NSC4 (specified maximum peak
at 365 nm, intensity 650 mW/cm2 at 4 cm distance).
Two microliter solvent was added to the dried sample spots
before direct analysis with a Protea Biosciences (Morgantown,
WV) LAESI DP-1000 system coupled to a Waters Synapt G2S
traveling wave ion mobility (IMS) time of flight (TOF) mass
spectrometer (MS). LAESI desktop software v.2.0.1.3 (Protea
Biosciences) was used to control experimental parameters of the
LAESI system. The Nd:YAG optical parametric oscillator mid-
infrared laser (2.94 μm) was set to 100% laser power (Φ 3.2 J/
cm2), and 10 pulses with a specified pulse length of 5 ns were
acquired on every spot (⌀ 200 μm) at a frequency of 5 Hz. A
solution of MeOH/H2O (1:1) with 0.1% FA and 40 ng ×mL
−1
leu-enk was used as electrospray solvent in positive ion mode
whereas in negative ion mode, a solution of MeOH/H2O (1:1)
with 100 ng ×mL−1 leu-enk was used. Electrospray flow rate
was 1 μL ×min−1 and the voltage was set at ~ 3.5 kV (ESI+) or
~ 3.0 kV (ESI−) in order to have a stable ESI signal. The Synapt
G2S was controlled by MassLynx v4.1 SCN 883 (Waters) and
operated in either positive—for verapamil, buspirone, and
testosterone—or negative—for ostarine and andarine—ion
TOF-MS resolution mode, m/z range 50–1200, scan time 1 s,
and source and interface temperatures were both set at 150 °C.
Background-subtracted mass spectra were generated using the
Bcombine spectrum^ function in MassLynx: five scans, each
corresponding to five laser pulses of UV exposed sample spots,
were combined and 50 scans, matching laser pulses of non-UV-
exposed sample spots (blank) together with electrospray back-
ground, were subtracted.
Time-Resolved TiO2 Photocatalysis LAESI-MS
For the time-resolved measurements, the UV lamp was
installed inside the LAESI system. Verapamil (1 mM)
was dissolved in 0.2 g × L−1 TiO2 nanopowder (H2O) and
the polypropylene sample cup containing the solution
(4 mL) was mounted inside the LAESI system. PEEK
tubing, connected to an air supply, was placed into the
solution to provide a continuous oxygen source as well as
a stirring mechanism due to the bubbling of air (5 mL ×
min−1). An overview of the experimental setup is shown in
Figure1b. The sample was online UV exposed for 60 min,
during which the mid-IR laser was pulsed continuously at
a frequency of 0.1 Hz, and MS scan time was 0.5 s. The
heated MS inlet temperature was decreased to 80 °C to
minimize solvent evaporation in the sample cup. Extracted
ion current (EIC) signals were integrated with MassLynx
and the (laser ablation-induced) peak areas obtained were
normalized to the verapamil [M+H]+ signal.
Results and Discussion
LAESI-MS as an Analysis Tool in TiO2--
Photocatalyzed Oxidation Reactions on Glass Slides
LAESI-MS was examined as a direct analysis tool in TiO2
photocatalysis; the generated oxidation products were crit-
ically compared with data of previously reported oxidation
products of the model compounds verapamil, buspirone,
and testosterone [7, 10, 11, 13, 20]. A first notable practi-
cal aspect was that LAESI, like DESI, was able to easily
analyze samples on surfaces without any sample pre-
treatment or lengthy chromatographic separation. Oxida-
tion products were generated by simple offline UV expo-
sure of analyte solutions on TiO2-coated glass slides, after
which LAESI analysis directly onto the glass slides proved
feasible. Additional analyte solution spots on the same
glass slides were covered to prevent UV exposure; the
obtained LAESI-MS signals of these spots were used for
MS background subtraction. Table 1 presents the obtained
photocatalyzed oxidation products of verapamil together
with their collision-induced dissociation (CID) MS/MS
product ions. Detected LAESI-ionized oxidation products
at m/z 291.206, 441.270, 487.282, and 469.266 correspond
to the molecular structures [M-164+H]+ (N-dealkylation),
[ M - CH 2 +H ]
+ ( d e m e t h y l a t i o n ) , [M + 2O+H ] +
(dihydroxylation), and [M+O-H2+H]
+ (carbonyl forma-
tion), respectively. Both the demethylation (M-CH2) and
carbonyl formation (M+O-H2) appear to occur at various
positions in the molecule. For the demethylation, this is
shown by the CID product ions m/z 151.076 and m/z
289.192 (Table 1, patterns B and C, respectively) that both
comprise CH2 (− 14.02 Da) loss. In the carbonyl
formation—oxidation product—this is indicated by the
two different CID product ions m/z 179.070 and m/z
317.187 (Table 1, patterns B and C, respectively), which
show a 13.98 Da addition (+O-H2) compared to their
verapamil equivalents. The observed photocatalyzed oxi-
dation products and CID product ions are similar to those
reported in TiO2-μPESI and DESI analysis studies [13,
20]. One exception is a product detected with TiO2-
μPESI-MS at m/z 195 (N-dealkylation) which was not
observed in our data. This absence could be a result of
the specific TiO2 photocatalysis procedure used, as with
TiO2-μPESI, the photocatalytic micropillar nanoreactor
was integrated in the electrospray ionization chip, which
comprises a different setup. Our method has more similar-
ities with the DESI study, in which m/z 195 was absent as
well [20]. The obtained verapamil CID fragmentation path-
way in Table 1 is similar to the one suggested by Walles
et al. [30]
For buspirone, the obtained TiO2-photocatalyzed oxida-
tion products following LAESI-ionization were m/z
402.254, 400.241, 384.240, and 418.253 and are presented
along with the their CID MS/MS product ions in Table 2.
The obtained oxidation products relate to the molecular
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structures [M+O+H]+ (hydroxylation), [M+O-H2+H]
+ (hy-
droxylation and dehydrogenation), [M-H2+H]
+ (dehydro-
genation), and [M+2O+H]+ (dihydroxylation), respective-
ly. As with verapamil, all obtained oxidation products are
in excellent agreement with LC-MS and DESI-MS studies
on this compound, underlining the feasibility of LAESI-
MS as a rapid analysis tool for TiO2 photocatalysis [7, 11,
20]. Furthermore, the obtained CID product ions D and F
(Table 2) of photocatalyzed oxidation products M+O (m/z
402.254) and M+O-H2 (m/z 400.241) in particular demon-
strate distinctive CID fragmentation. The hydroxylation
(M+O) product suggests a rapid loss of H2O upon CID,
making the hydroxylation site undetected in CID MS/MS
analysis from the m/z values of fragment ions D and F.
However, with the hydroxylation and dehydrogenation
(M+O-H2) product, this site is indicated to be in CID
product ion F due to the increased m/z value of this CID
product ion (from m/z 265 to 279). The dehydrogenation
site is located in the piperazine moiety, as indicated by
CID MS/MS product ion E (m/z 162.090, Table 2). The
opportunity to include CID MS/MS is a useful option, but
a minor shortcoming of ambient ionization MS compared
Figure 1. Schematic overview of TiO2 photocatalysis LAESI-MS. (a) Offline UV exposure of samples on TiO2-coated glass slides
followed by direct LAESI-MS analysis. (b) The online time-resolved TiO2 photocatalysis LAESI-MS setup, comprising an ESI probe, a
sample cup with PEEK tube for oxygen supply, a mid-IR laser, and a 365 nm UV lamp. Additional details can be found in the
experimental section and a picture of (b) is shown in Figure S1
Table 1. Observed TiO2 Photocatalyzed Oxidation Products of Verapamil, as Generated on TiO2-Coated Glass Slides, Together with Their CID Product Ions. A
Background-Subtracted Mass Spectrum Is Given in Figure S2a and CID MS/MS Spectra of Verapamil and Photocatalyzed Oxidation Products Are Provided in
Figure S3
Photocatalytic oxidation product [M+H]+ Observed CID MS/MS product ions (m/z)
A B C D E Other
Verapamil 455.290 150.068 165.091 303.206 260.165



















Proposed CID fragmentation pattern of verapamil
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to hyphenated-MS techniques is the absence of the extra
separation dimension, e.g., there were four chromatograph-
ic peaks reported by Calza et al. in the LC-MS analysis of
hydroxy-buspirone (m/z 402), corresponding to at least
four different isobaric hydroxylation products [7]. An ad-
ditional separation dimension compatible with ambient
ionization MS is ion mobility (IMS) [26]. The applicability
of IMS was investigated by calculation of collision cross
sections (CCS) for reported isobaric hydroxylation prod-
ucts and is provided in Table S1 [7]. Buspirone hydroxyl-
ation products are varying in CCS by circa 1%, whereas
the IMS resolving power of used instrumentation is capa-
ble of separating compounds with CCS differences of over
approximately 5% [31]. The IMS separation of buspirone
hydroxylation products is therefore beyond the resolving
power of present instrumentation and was not further in-
vestigated here. Nonetheless, studies comprising other
molecules and/or different ion mobility hardware could
benefit from separation with this technique. The CID MS/
MS fragmentation pathway as proposed in Table 2 is in
good agreement with literature [7, 32].
Finally, the steroid testosterone was studied to show the
feasibility of TiO2 photocatalysis LAESI-MS for analysis of a
more hydrophobic compound. Testosterone was dissolved in
H2O/ACN (1:1 v/v) prior to the analysis. ACN is known to be
an OH radical scavenger and may therefore somewhat hamper
the TiO2-photocatalyzed oxidation of testosterone [10, 33].
Despite this organic modifier, oxidation products were easily
obtained and are presented with their CIDMS/MS product ions
in Table S2. The observed reaction products M+O (m/z
305.209), M+O-H2 (m/z 303.194), and M-H2 (m/z 287.203)
are in line with the products detected in conventional LC-MS
analysis [10, 11].
TiO2 Photocatalysis LAESI-MS of Selective
Androgen Receptor Modulators on Glass Slides
Following the verification of LAESI-MS as a suitable
analysis tool in TiO2 photocatalysis on glass slides, the
method was used to study the oxidation products of the
selective androgen receptor modulators andarine and
ostarine. The only photocatalytic reaction product of
andarine was observed at m/z 307.058 (Figure 2a) follow-
ing LAESI-MS analysis, and the proposed mechanism is
depicted in Figure S6. The proposed structure could further
be confirmed by MS/MS of m/z 307.058, via the observa-
tion of a fragment ion at m/z 205.023. This m/z 307.058
peak and similar MS/MS spectra were reported to belong
to the most abundant metabolite in several biological
in vitro and in vivo studies, using human liver microsomes
and human urine [34–40]. In those studies, reported phase
II metabolites produced by enzymes, such as glutathione-
S-transferase, N-acetyl transferase, and sulfotransferase,
are obviously not observed in TiO2-photocatalyzed oxida-
tion studies.
In case of ostarine, the LAESI-ionized oxidation products
were observed at m/z 287.062 and m/z 404.093 (Figure 2b).
The ion at m/z 287.062 is proposed to be produced following a
similar reaction mechanism (Figure S6) as m/z 307.058 of
andarine. The structure is further confirmed byMS/MS to yield
a CID fragment ion atm/z 185.033, which is in agreement with
literature [40, 41]. The oxidation product appearing at m/z
Table 2. Observed TiO2-Photocatalyzed Oxidation Products of Buspirone, and Their CIDMS/MS Product Ions. A Background-SubtractedMass Spectrum Is Given
in Figure S2b and CID MS/MS Spectra of Buspirone and Photocatalyzed Oxidation Products Are Provided in Figure S4
Photocatalytic oxidation product [M+H]+ Observed CID MS/MS product ions (m/z)
A B C D E F G Other
Buspirone 386.255 222.149 150.103 122.072 265.191
M+O 402.254 222.149 251.176 122.072 265.192 384.240
M+O-H2 400.241 122.072 279.170 150.067 372.240
M-H2 384.240 222.149 162.090




Proposed CID fragmentation pattern of buspirone
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404.093 is most likely formed by hydroxylation of ostarine.
Multiple hydroxylation sites were identified by MS/MS exper-
iments. The most obvious sites are aromatic rings (Figure S7).
The CID fragment ions at m/z 285.049 and m/z 118.030 corre-
spond to hydroxylation in aromatic ring A, whereas the frag-
ment ions at m/z 269.054 and m/z 134.025 associate with
hydroxylation at ring B. A fragmentation mechanism for these
compounds has been reported previously [33]. However, we
here propose a different CID fragmentation mechanism, lead-
ing to fragment ions with a stable C-N bond instead of a labile
N-O bond (Figure S7b). These results demonstrate that our
method provides rapid identification of photocatalyzed
oxidation products that mimic products found in several
in vitro studies [34–41].
Although both andarine and ostarine do not significantly
absorb UV light at λ = 365 nm, the same experiment, but on
regular—uncoated—glass slides was performed to exclude any
possibility of photodegradation due to direct UV exposure.
Indeed, no reaction products were obtained (Figure S10).
Please note that all compounds used in this study do not
significantly absorb UV light at λ > 300 nm and the used UV
lamp does not emit UV light at λ < 350 nm (Figure S11). It is
therefore unlikely that any products shown in this work are a
result of photodegradation.
Figure 2. Background-subtracted mass spectra of the oxidation products of andarine (a) and ostarine (b), with their proposed
structures. Obtained CID MS/MS spectra are provided in Figures S7 (ostarine product, m/z 404.093), S8 (andarine product, m/z
307.058), and S9 (ostarine product, m/z 287.062)
Figure 3. Time-resolved photocatalyzed oxidation LAESI-MS of verapamil using a TiO2 nanoparticle suspension. (a) The formation
of theN-dealkylation product (m/z 291.21) of verapamil. (b) The formation of the demethylation product of verapamil (m/z 441.28). (c)
The product of both the N-dealkylation and demethylation (m/z 277.19), which starts to appear around ~ 25 min (intensity shown at
secondary y-axis). The 365-nm UV lamp was switched ON after 2 min. All lines were normalized to verapamil [M+H]+. Data were
averaged (n = 3, for clarity, error bars are not shown), individual data are shown in Figure S14
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Time-Resolved Photocatalyzed Oxidation
LAESI-MS of Verapamil Using TiO2 Nanoparticle
Suspensions
In order to monitor the generation of reaction products in time,
an online setup was created by installing a reaction cup and the
UV lamp inside the LAESI system (Figures 1b and S1). Be-
sides measuring oxidation products from TiO2-coated glass
slides as demonstrated in the previous paragraphs, LAESI is
also capable of measuring those directly from a sample cup
containing suspended TiO2 nanoparticles in water. Verapamil
was used as a model compound and the generation of several
products during a reaction time of 1 h is shown in Figure 3.
After switching on the 365-nm UV lamp, at 2-min runtime,
almost instantly two major products of verapamil, the N-
dealkylation and demethylation products (Figure 3, signals a
and b) were observed. These reaction products steadily in-
creased in abundance during the entire analysis runtime of
60 min (Figure 3, raw data in Figure S12). The added value
of time-resolved analysis started to show after ca. 25-min
reaction time, when a product ion at m/z 277.19 started to
appear (Figure 3, signal c). This m/z value is the result of both
N-dealkylation and demethylation of verapamil and clearly
demonstrates the power of this system in identifying subse-
quent oxidation steps. In addition, also the product of a double
demethylation (m/z 427.26) was observed after ca. 18 min
(Figure S13). Following these results, this time-resolved meth-
od allows the optimization of reaction conditions preliminary
to high-throughput static experiments. Despite the inherent
poor reproducibility of MS data from individual LAESI pulses,
the reproducibility of time-resolved TiO2 photocatalyzed
LAESI-MS over three different analyses is actually quite good,
cf. the individual lines of the (n = 3) averaged data presented in
Figure 3 given in Figure S14. This indicates that time-resolved
analysis of the oxidation products of drugs is not only feasible
by LAESI, but also easily adds mechanistic information that is
not available upon analysis of the composition of just one time
point.
Conclusions
We have developed an ambient TiO2 photocatalysis LAESI
MS method to generate photocatalyzed oxidation products of
drugs that are similar to phase I metabolites. Like other ambient
ionizationMS approaches the concept features rapid simplified
analysis without any sample pretreatment or lengthy chromato-
graphic separations. In addition, LAESI MS was able to mea-
sure drugs and their metabolites directly from the surface of
TiO2-coated glass slides as well as from TiO2 nanoparticle
suspensions. Among others, the method on TiO2-coated glass
slides was demonstrated with the selective androgen receptor
modulators andarine and ostarine to yield oxidation reaction
products similar to those obtained in various in vitro studies.
Moreover, a novel fully integrated, time-resolved LAESI MS
photocatalyzed oxidation approachwas successfully developed
using a TiO2 nanoparticle suspension and demonstrated for
verapamil. The time-resolved TiO2 photocatalysis LAESI MS
exhibited excellent stability and enabled the monitoring of
reaction products during a reaction time of at least 1 h. This
method can be used in future research to expeditiously assess
drug candidates in the early stages of development as well as an
online tool for time-resolved monitoring for this and of
other—non-TiO2 based—reactions.
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